CoChat

Advanced Glycation Endproducts and Bone Material Properties in Type 1 Diabetic Mice

Open access

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Abstract

Fractures, particularly at the lower extremities and hip, are a complication of diabetes. In both type 1 (T1D) and type 2 diabetes (T2D), fracture risk is disproportionately worse than that predicted from the measurement of bone mineral density. Although an explanation for this discrepancy is the presence of organic matrix abnormalities, it has not been fully elucidated how advanced glycation endproducts (AGEs) relate to bone deterioration at both the macroscopic and microscopic levels. We hypothesized that there would be a relationship between skeletal AGE levels (determined by Raman microspectroscopy at specific anatomical locations) and bone macroscopic and microscopic properties, as demonstrated by the biomechanical measures of crack growth and microindentation respectively. We found that in OVE26 mice, a transgenic model of severe early onset T1D, AGEs were increased by Raman (carboxymethyl-lysine [CML] wildtype (WT): 0.0143 ±0.0005 vs T1D: 0.0175 ±0.0002, p = 0.003) at the periosteal surface. These differences were associated with less tough bone in T1D by fracture mechanics (propagation toughness WT: 4.73 ± 0.32 vs T1D: 3.39 ± 0.24 NM/m1/2, p = 0.010) and by reference point indentation (indentation distance increase WT: 6.85 ± 0.44 vs T1D: 9.04 ± 0.77 μm; p = 0.043). Within T1D, higher AGEs by Raman correlated inversely with macroscopic bone toughness. These data add to the existing body of knowledge regarding AGEs and the relationship between skeletal AGEs with biomechanical indices.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0154700

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Analysis of different standard references by Raman microspectroscopy to confirm the Raman marker bands for pentosidine (PEN) and carboxymethyl-lysine (CML). The Raman measurements and spectra treatments were as described in Materials and Methods. The bone Raman spectra was obtained from the periosteal surface of a heathy and diabetic mouse. The Raman marker bands for PEN (~1495 cm-1) and CML (~1150 cm-1) are highlighted. The purified collagen Raman spectra from a human bone was kindly provided by Dr. Robins and the proteoglycan and lysine references were purchased from Sigma Aldrich. Both AGEs references (PEN and CML) were purchased from PolyPeptide Laboratories France SAS.
Fig 1 Analysis of different standard references by Raman microspectroscopy to confirm the Raman marker bands for pentosidine (PEN) and carboxymethyl-lysine (CML). The Raman measurements and spectra treatments were as described in Materials and Methods. The bone Raman spectra was obtained from the periosteal surface of a heathy and diabetic mouse. The Raman marker bands for PEN (~1495 cm-1) and CML (~1150 cm-1) are highlighted. The purified collagen Raman spectra from a human bone was kindly provided by Dr. Robins and the proteoglycan and lysine references were purchased from Sigma Aldrich. Both AGEs references (PEN and CML) were purchased from PolyPeptide Laboratories France SAS.CC BY · PubMed Central
Fig 2 AGE measurement in the femoral bones of wildtype and diabetic mice. Raman microspectroscopic measurement of CML (panel A) and pentosidine (panel B) showed an increase in diabetic OVE26 mice (n = 6) as compared to wildtype FVB mice (n = 6); *p<0.05; **p<0.001. The mean value is indicated by the grey diamond; the median by the horizontal line; the 25% and 75% by the boxes and the 95% confidence interval by the bars.
Fig 2 AGE measurement in the femoral bones of wildtype and diabetic mice. Raman microspectroscopic measurement of CML (panel A) and pentosidine (panel B) showed an increase in diabetic OVE26 mice (n = 6) as compared to wildtype FVB mice (n = 6); *p<0.05; **p<0.001. The mean value is indicated by the grey diamond; the median by the horizontal line; the 25% and 75% by the boxes and the 95% confidence interval by the bars.CC BY · PubMed Central
Fig 3 Matrix Properties by Raman Spectroscopy in femoral bones. Raman microspectroscopic measurement showed a decrease in mineral/matrix ratio [v2PO4/Amide III] (panel A) and in relative lipids content [lipids/Amide III] (panel B) in diabetic OVE26 mice (n = 6) as compared to wildtype FVB mice (n = 6). Mineral maturity/crystallinity [FWHH V1PO4] did not differ (panel C) in diabetic OVE26 mice. In contrast, relative pyridinoline content was increased in diabetic OVE26 mice (panel D), while there was no difference in relative proteoglycan content [PG/ Amide III] (panel E). The mean value is indicated by the grey diamond; the median by the horizontal line; the 25% and 75% by the boxes and the 95% confidence interval by the bars.
Fig 3 Matrix Properties by Raman Spectroscopy in femoral bones. Raman microspectroscopic measurement showed a decrease in mineral/matrix ratio [v2PO4/Amide III] (panel A) and in relative lipids content [lipids/Amide III] (panel B) in diabetic OVE26 mice (n = 6) as compared to wildtype FVB mice (n = 6). Mineral maturity/crystallinity [FWHH V1PO4] did not differ (panel C) in diabetic OVE26 mice. In contrast, relative pyridinoline content was increased in diabetic OVE26 mice (panel D), while there was no difference in relative proteoglycan content [PG/ Amide III] (panel E). The mean value is indicated by the grey diamond; the median by the horizontal line; the 25% and 75% by the boxes and the 95% confidence interval by the bars.CC BY · PubMed Central
Fig 4 Mechanical indices in the femoral bones of wildtype and diabetic mice. Fracture toughness testing demonstrated decreased initiation (panel A) and propagation (panel B) toughness in diabetic OVE26 (n = 6) vs wildtype FVB (n = 6) mice. Reference point indentation showed increased IDI (indentation distance increase; panel C) and a tendency toward increased TID (total indentation distance; panel D). The mean value is indicated by the grey diamond; the median by the horizontal line; the 25% and 75% by the boxes and the 95% confidence interval by the bars.
Fig 4 Mechanical indices in the femoral bones of wildtype and diabetic mice. Fracture toughness testing demonstrated decreased initiation (panel A) and propagation (panel B) toughness in diabetic OVE26 (n = 6) vs wildtype FVB (n = 6) mice. Reference point indentation showed increased IDI (indentation distance increase; panel C) and a tendency toward increased TID (total indentation distance; panel D). The mean value is indicated by the grey diamond; the median by the horizontal line; the 25% and 75% by the boxes and the 95% confidence interval by the bars.CC BY · PubMed Central
Fig 5 Correlation in diabetic mice between AGEs by Raman microspectroscopy and mechanical indices. Within diabetic OVE26 (n = 6) mice, CML (A) and pentosidine (B) correlated inversely with propagation toughness (r = -0.99, p<0.001 and r = -0.97, p = 0.001, respectively).
Fig 5 Correlation in diabetic mice between AGEs by Raman microspectroscopy and mechanical indices. Within diabetic OVE26 (n = 6) mice, CML (A) and pentosidine (B) correlated inversely with propagation toughness (r = -0.99, p<0.001 and r = -0.97, p = 0.001, respectively).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 57 references

Cited by

Metadata

Authors
Rubin, M. R., Paschalis, E. P., Poundarik, A., Sroga, G. E., McMahon, D. J., Gamsjaeger, S., Klaushofer, K., & Vashishth, D.
Affiliations
  • Columbia University (US)
  • Hanusch Hospital (AT)
  • Rensselaer Polytechnic Institute (US)
Corresponding author
Rubin, Mishaela R.
Venue
PLOS ONE
Published
2016-05-03
Volume
11
Issue
5
Pages
e0154700
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2346226609
Cited by
90
References
57
Citations by year
2026: 6 · 2025: 1 · 2024: 6 · 2023: 13 · 2022: 8 · 2021: 8 · 2020: 14 · 2019: 15 · 2018: 10 · 2017: 6 · 2016: 3
FWCI
13.81
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Columbia University Irving Institute for Clinical and Translational Research (CTSA/CTO pilot award)
  • National Institutes of Health (AR 49635, AG 20618)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Keywords
advanced glycation end products, type 1 diabetes, bone biomechanics, fracture risk, carboxymethyllysine, bone toughness, microindentation, micro-Raman spectroscopy, bone organic matrix
MeSH terms
Animals, Biomechanical Phenomena, Bone and Bones, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 1, Female, Bone Density, Glycation End Products, Advanced, Fractures, Bone, Mice, Mechanical Phenomena

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.